GENETIC AND BIOCHEMICAL STUDY OF HUMAN CHROMOSOME 21
人类 21 号染色体的遗传和生物化学研究
基本信息
- 批准号:3322533
- 负责人:
- 金额:$ 9.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1991
- 资助国家:美国
- 起止时间:1991-07-01 至 1992-03-31
- 项目状态:已结题
- 来源:
- 关键词:Downs syndrome acyltransferase chromosomes complementary DNA gel electrophoresis genetic library genetic manipulation genetic mapping genetic markers human genetic material tag human tissue laboratory rabbit laboratory rat ligase linkage mapping molecular genetics nucleic acid probes nucleic acid sequence purine /pyrimidine metabolism purines trisomy
项目摘要
Down Syndrome (Trisomy 21) is the most common genetic cause of major mental
retardation in the United States and a significant cause of congenital
heart disease and spontaneous abortion. Down syndrome individuals are at
increased risk for diseases which occur in the general population such as
leukemia and premature aging of the Alzheimer's type. Down Syndrome
patients have been found to be hyperuricemic, and evidence indicating that
this is due to purine overproduction has been obtained. We have shown that
at least 2 of the enzymes coding for purine biosynthesis are coded for by
genes on chromosome 21. We have purified one of these,
phosphoribosylglycineamide synthetase (GARS), to apparent homogeneity from
rat liver and prepared antibody to it. We have also shown that in
Drosophila the genes for GARS and for phosphoribosylaminoimidazole
synthetase (AIRS) also on chromosome 21 in humans, are on the same cloned
DNA sequence as the gene for phosphoribosylglycineamide formyltransferase
(GART) cloned by Dr. S. Henikoff. We now propose 1) to determine whether
the elevated purine levels seen in Down syndrome patients are related to
the presence of these genes on chromosome 21 and to the pathology of Down
Syndrome, and 2) to use the unique genetic system afforded by the locations
of the genes for enzymes of purine synthesis on chromosome 21 to understand
the nature of the pathogenetic region on chromosome 21, whether or not
purine synthesis is related directly to the observed pathology. Specific
aims include characterization of the enzymes of purine synthesis coded for
by genes on chromosome 21 and isolation and characterization of the genes
themselves, determination of whether rate of purine synthesis varies
according to chromosome 21 content, and the creation of a detailed
retriction enzyme and physical linkage map of the region of chromsosome 21
important for Down Syndrome, using the genes for enzymes of purine
synthesis as a starting point.
唐氏综合征(21三体)是最常见的遗传性主要精神疾病的原因。
在美国的一个重要原因是先天性发育迟缓,
心脏病和自然流产。 唐氏综合症患者在
增加普通人群发生疾病的风险,例如
白血病和老年痴呆症的早衰。 唐氏综合症
已发现患者患有高尿酸血症,有证据表明
这是由于嘌呤的过量产生。 我们已经证明
编码嘌呤生物合成的酶中的至少2种由以下编码:
21号染色体上的基因 我们净化了其中一个,
磷酸核糖基甘氨酸酰胺合成酶(加尔斯),从
并制备了抗鼠肝纤维化的抗体。
果蝇的加尔斯和磷酸核糖氨基咪唑基因
合成酶(AIRS)也在人类21号染色体上,
作为磷酸核糖基甘氨酸酰胺甲酰基转移酶基因的DNA序列
(GART)由S.赫尼科夫 我们现在建议1)确定是否
在唐氏综合征患者中观察到的升高的嘌呤水平与
这些基因在21号染色体上的存在和唐氏症的病理学
综合征,以及2)使用由位置提供的独特遗传系统
嘌呤合成酶的基因,
21号染色体上致病区域的性质,
嘌呤合成与观察到的病理学直接相关。 具体
目的包括表征编码嘌呤合成的酶,
通过21号染色体上的基因以及基因的分离和表征
它们本身,确定嘌呤合成的速率是否变化
根据染色体21的内容,并创建一个详细的
21号染色体区域的限制酶和物理连锁图谱
对唐氏综合症很重要,利用嘌呤酶的基因
综合作为起点。
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Somatic cell genetic approaches to Down's syndrome.
唐氏综合症的体细胞遗传学方法。
- DOI:10.1111/j.1749-6632.1982.tb26844.x
- 发表时间:1982
- 期刊:
- 影响因子:5.2
- 作者:Patterson,D;Jones,C;Scoggin,C;Miller,YE;Graw,S
- 通讯作者:Graw,S
Two Drosophila melanogaster mutations block successive steps of de novo purine synthesis.
- DOI:10.1073/pnas.83.11.3919
- 发表时间:1986-06
- 期刊:
- 影响因子:11.1
- 作者:S. Henikoff;D. Nash;R. Hards;J. Bleskan;J. Woolford;F. Naguib;D. Patterson
- 通讯作者:S. Henikoff;D. Nash;R. Hards;J. Bleskan;J. Woolford;F. Naguib;D. Patterson
Fractionation of large mammalian DNA restriction fragments using vertical pulsed-field gradient gel electrophoresis.
使用垂直脉冲场梯度凝胶电泳对大型哺乳动物 DNA 限制性片段进行分级分离。
- DOI:10.1007/bf01560665
- 发表时间:1986
- 期刊:
- 影响因子:0
- 作者:Gardiner,K;Laas,W;Patterson,D
- 通讯作者:Patterson,D
Demonstration, by somatic cell genetics, of coordinate regulation of genes for two enzymes of purine synthesis assigned to human chromosome 21.
- DOI:10.1073/pnas.78.1.405
- 发表时间:1981
- 期刊:
- 影响因子:11.1
- 作者:D. Patterson;S. Graw;C. Jones
- 通讯作者:D. Patterson;S. Graw;C. Jones
Measurement of glycinamide ribonucleotide synthetase activity in intact human fibroblasts and Chinese hamster ovary cells.
完整人成纤维细胞和中国仓鼠卵巢细胞中甘氨酰胺核糖核苷酸合成酶活性的测量。
- DOI:10.1159/000469333
- 发表时间:1986
- 期刊:
- 影响因子:0
- 作者:Hards,RG;Patterson,D
- 通讯作者:Patterson,D
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID PATTERSON其他文献
DAVID PATTERSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID PATTERSON', 18)}}的其他基金
Proteomics for Testing Hypotheses about Down Syndrome
用于检验唐氏综合症假设的蛋白质组学
- 批准号:
7248057 - 财政年份:2004
- 资助金额:
$ 9.7万 - 项目类别:
Proteomics for Testing Hypotheses about Down Syndrome
用于检验唐氏综合症假设的蛋白质组学
- 批准号:
6926190 - 财政年份:2004
- 资助金额:
$ 9.7万 - 项目类别:
Proteomics for Testing Hypotheses about Down Syndrome
用于检验唐氏综合症假设的蛋白质组学
- 批准号:
7082872 - 财政年份:2004
- 资助金额:
$ 9.7万 - 项目类别:
Proteomics for Testing Hypotheses about Down Syndrome
用于检验唐氏综合症假设的蛋白质组学
- 批准号:
6826136 - 财政年份:2004
- 资助金额:
$ 9.7万 - 项目类别:
AUTISM AND AMPS LYASE MUTATIONS: CELL AND MOUSE MODELS
自闭症和 AMPS 裂解酶突变:细胞和小鼠模型
- 批准号:
6579811 - 财政年份:2003
- 资助金额:
$ 9.7万 - 项目类别:
AUTISM AND AMPS LYASE MUTATIONS: CELL AND MOUSE MODELS
自闭症和 AMPS 裂解酶突变:细胞和小鼠模型
- 批准号:
6868232 - 财政年份:2003
- 资助金额:
$ 9.7万 - 项目类别:
AUTISM AND AMPS LYASE MUTATIONS: CELL AND MOUSE MODELS
自闭症和 AMPS 裂解酶突变:细胞和小鼠模型
- 批准号:
6703721 - 财政年份:2003
- 资助金额:
$ 9.7万 - 项目类别:
AUTISM AND AMPS LYASE MUTATIONS: CELL AND MOUSE MODELS
自闭症和 AMPS 裂解酶突变:细胞和小鼠模型
- 批准号:
7172954 - 财政年份:2003
- 资助金额:
$ 9.7万 - 项目类别:
AUTISM AND AMPS LYASE MUTATIONS: CELL AND MOUSE MODELS
自闭症和 AMPS 裂解酶突变:细胞和小鼠模型
- 批准号:
7012827 - 财政年份:2003
- 资助金额:
$ 9.7万 - 项目类别:
PURINE, FOLATE, AND REACTIVE OXYGEN METABOLISM AND DOWN SYNDROME
嘌呤、叶酸和活性氧代谢与唐氏综合症
- 批准号:
6301897 - 财政年份:2000
- 资助金额:
$ 9.7万 - 项目类别:
相似海外基金
Design of chemical probes for hedgehog acyltransferase
Hedgehog酰基转移酶化学探针的设计
- 批准号:
2600595 - 财政年份:2022
- 资助金额:
$ 9.7万 - 项目类别:
Studentship
Identification of the glycolytic enzyme palmitoyl acyltransferase
糖酵解酶棕榈酰酰基转移酶的鉴定
- 批准号:
571756-2022 - 财政年份:2022
- 资助金额:
$ 9.7万 - 项目类别:
University Undergraduate Student Research Awards
The role of LYCAT acyltransferase in phagocytosis and immune function
LYCAT酰基转移酶在吞噬作用和免疫功能中的作用
- 批准号:
564899-2021 - 财政年份:2021
- 资助金额:
$ 9.7万 - 项目类别:
University Undergraduate Student Research Awards
Targeting a Human Acyltransferase for Broad-Spectrum Antivirals
靶向人类酰基转移酶的广谱抗病毒药物
- 批准号:
10223496 - 财政年份:2021
- 资助金额:
$ 9.7万 - 项目类别:
Hedgehog acyltransferase : structure and function in health and disease
Hedgehog酰基转移酶:健康和疾病中的结构和功能
- 批准号:
BB/T01508X/1 - 财政年份:2020
- 资助金额:
$ 9.7万 - 项目类别:
Research Grant
Is transcription factor TEAD a missing protein lysine fatty acyltransferase?
转录因子 TEAD 是缺失的蛋白质赖氨酸脂肪酰基转移酶吗?
- 批准号:
19K22271 - 财政年份:2019
- 资助金额:
$ 9.7万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Protein acyltransferase mediated S-palmitoylation and its Importance in Innate Immunity and Lipid Metabolism.
蛋白质酰基转移酶介导的 S-棕榈酰化及其在先天免疫和脂质代谢中的重要性。
- 批准号:
401169 - 财政年份:2019
- 资助金额:
$ 9.7万 - 项目类别:
Operating Grants
Basic research on the development of therapeutic agents for Alzheimer's disease using Acyl-CoA:cholesterol acyltransferase inhibitor
利用酰基辅酶A:胆固醇酰基转移酶抑制剂开发阿尔茨海默病治疗剂的基础研究
- 批准号:
19K07093 - 财政年份:2019
- 资助金额:
$ 9.7万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Defining the Molecular Architecture for Transmembrane Acylation by a Membrane Bound O-Acyltransferase
定义膜结合 O-酰基转移酶跨膜酰化的分子结构
- 批准号:
10246913 - 财政年份:2019
- 资助金额:
$ 9.7万 - 项目类别:
Characterization of Xenopus laevis DHAP acyltransferase
非洲爪蟾 DHAP 酰基转移酶的表征
- 批准号:
540689-2019 - 财政年份:2019
- 资助金额:
$ 9.7万 - 项目类别:
University Undergraduate Student Research Awards














{{item.name}}会员




